🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05794152
Recruiting Not applicable

Wenzhou Gestational Diabetes Cohort

NCT05794152 · tracked via the Priya Life Science China tracker
Sponsor
Westlake University
Phase
Not applicable
Started
2023-03-21
Last updated
2025-04-03

Condition(s) studied

Gestational Diabetes MellitusIntrauterine HyperglycemiaBirth Outcome, AdverseNutrition, Healthy

Investigational drug(s) / intervention(s)

Standardized breakfastStandardized snackStandardized lunch

Standardized breakfast: Participants will be provided with a standardized breakfast on a morning of the days they wear a continuous glucose monitoring (CGM) device.

Standardized snack: Participants will be provided with a standardized snack 2 hour after they have the standardized breakfast.

Standardized lunch: Participants will be provided with a standardized lunch 2 h after they have the standardized snack.

Study summary

The Wenzhou Gestational Diabetes Cohort (WGDC) is a prospective cohort study among women with gestational diabetes mellitus (GDM) during pregnancy and their offspring living in Wenzhou, China. The primary aim of this cohort is to characterize the continuous blood glucose response to dietary intake and physical activity among pregnant women with GDM over 2 weeks, and to facilitate the development of personalized nutritional/lifestyle recommendation among these patients. Another aim of the WGDC is to investigate the association of dietary and physical activity together with continuous glucose change during pregnancy on the adverse birth outcomes including preterm birth, macrosomia and large-for-gestational-age birth. The secondary aim is to investigate the prospective associations of diet, physical activity and continuous glucose change over 2 weeks among the patients with long-term metabolic health of the women and their offspring.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Women aged 18 years or older * Women with GDM mainly at 24-28 weeks of gestation * Women intended to deliver at Wenzhou People's Hospital * Women intended to remain in Wenzhou with their child for ≥4 years Exclusion Criteria: * Women with cancer and other serious medical disorders

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wenzhou People's Hospital Wenzhou Zhejiang Recruiting

More Westlake University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05794152 on ClinicalTrials.gov ↗ ← All trials in China